Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients (Q42023933)

15 October 2017

Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients (English)

1 reference

Streptococcus milleri group

15 October 2017

0 references

1 reference

object named as

Streptococcus milleri

1 reference

6

Michael G Surette

1 reference

15 October 2017

Margot E Grinwis

1

1 reference

15 October 2017

Christopher D Sibley

2

1 reference

15 October 2017

Michael D Parkins

3

1 reference

15 October 2017

Christina S Eshaghurshan

4

1 reference

15 October 2017

Harvey R Rabin

5

1 reference

15 October 2017

language of work or name

English

0 references

publication date

19 April 2010

1 reference

15 October 2017

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

15 October 2017

54

1 reference

15 October 2017

7

1 reference

15 October 2017

2823-2829

1 reference

Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: a case series and literature review

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Retrospective analysis of 49 cases of brain abscess and review of the literature

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Clinically significant infections with organisms of the Streptococcus milleri group

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Trends in antimicrobial susceptibility of the Streptococcus milleri group

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Acute bronchopulmonary infection due to Streptococcus milleri in a child with cystic fibrosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Erythromycin resistance by ribosome modification

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Microbiology of pyogenic liver abscess.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Bacteriology of abscesses of the central nervous system: a multicentre prospective study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Relevance of group Milleri streptococci in thoracic surgery: a clinical update.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Prospective study of Streptococcus milleri hepatic abscess

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Thoracic Empyema in Patients with Community-Acquired Pneumonia

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897290

Antimicrobial Susceptibilities of Species of Viridans Streptococci

30 September 2018

1 reference

12 December 2020

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

1 reference

12 December 2020

Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group

1 reference

12 December 2020

The Streptococcus milleri group as a cause of pulmonary infections

1 reference

12 December 2020

Thoracic infection caused by Streptococcus milleri

1 reference

12 December 2020

A study of susceptibility of 100 clinical isolates belonging to the Streptococcus milleri group to 16 cephalosporins

1 reference

12 December 2020

Aetiological agents, interleukin-6, interleukin-8 and CRP concentrations in children with community- and hospital-acquired pneumonia

1 reference

12 December 2020

Clinical analysis of cases of empyema due to Streptococcus milleri group

1 reference

12 December 2020

McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients

1 reference

12 December 2020

Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis

1 reference

12 December 2020

The importance of recognising Streptococcus milleri as a cause of orbital cellulitis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.01845-09

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

20404127

1 reference